Tien Liang BioTech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-3.25	11.7	17.73	59.48	46.61	-51.64
Depreciation & Amortization	9.6	9.15	10.44	10.76	11.97	14.3
Other Amortization	0.19	0.16	0.11	0.29	0.46	0.55
Loss (Gain) From Sale of Assets	2.5	0.68	-0.57	-0.03	-	-0.16
Asset Writedown & Restructuring Costs	-	-	-	-	-	1.31
Loss (Gain) From Sale of Investments	-2.39	-2.93	-	-	-	-
Other Operating Activities	13.5	-8.03	-0.66	-0.02	2.23	-1.11
Change in Accounts Receivable	-16.09	-0.73	15.42	-3.4	-4.69	13.71
Change in Inventory	0.38	17.31	19.17	-34.02	-8.37	5.25
Change in Accounts Payable	35.29	10.96	-1.2	-8.91	6.29	-9.53
Change in Unearned Revenue	-	-	-	-	-2.89	0.38
Change in Other Net Operating Assets	20.53	10.09	9.23	-2.27	-6.4	16.13
Operating Cash Flow	60.26	48.34	69.67	21.88	45.21	-10.82
Operating Cash Flow Growth	27.84%	-30.61%	218.42%	-51.60%	-	-
Capital Expenditures	-17.01	-4.05	-4.96	-1.01	-0.6	-1.09
Sale of Property, Plant & Equipment	1.91	3.84	0.6	0.1	-	0.16
Sale (Purchase) of Intangibles	-0.23	-0.1	-0.38	-	-	-0.4
Investment in Securities	-385.17	-300.13	-	-	-	1.2
Other Investing Activities	0.74	-1.08	-0.03	-0.3	-0.58	0.48
Investing Cash Flow	-399.76	-301.51	-4.78	-1.21	-1.18	0.35
Short-Term Debt Issued	-	265	-	-	-	88.79
Total Debt Issued	397.63	265	-	-	-	88.79
Short-Term Debt Repaid	-	-	-30	-30.5	-40	-
Long-Term Debt Repaid	-	-0.5	-0.52	-0.8	-0.8	-50.38
Total Debt Repaid	-0.5	-0.5	-30.52	-31.3	-40.8	-50.38
Net Debt Issued (Repaid)	397.12	264.5	-30.52	-31.3	-40.8	38.41
Common Dividends Paid	-	-22.88	-	-	-	-
Financing Cash Flow	397.12	241.62	-30.52	-31.3	-40.8	38.41
Net Cash Flow	57.62	-11.55	34.37	-10.63	3.23	27.94
Free Cash Flow	43.25	44.3	64.71	20.87	44.61	-11.91
Free Cash Flow Growth	-3.60%	-31.54%	210.05%	-53.22%	-	-
Free Cash Flow Margin	9.26%	11.50%	14.07%	3.95%	7.81%	-2.76%
Free Cash Flow Per Share	0.94	0.97	1.41	0.46	0.97	-0.26
Cash Interest Paid	8.96	2.89	2.1	1.69	1.8	1.92
Cash Income Tax Paid	0.12	0.82	0.06	0.01	-0	-0.01
Levered Free Cash Flow	24.02	52.22	56.67	-4.55	20.7	2.82
Unlevered Free Cash Flow	29.62	54.15	57.97	-3.44	21.86	4.05
Change in Working Capital	40.11	37.62	42.62	-48.6	-16.05	25.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.